# Levostar

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/levostar

- Industry: Biotechnology
- Headquarters: Suzhou, China
- Website: www.levostar.com
- Latest round: Seed (Apr 11, 2022)
- Investors on record: 2

## About

Based in Suzhou, China, and established in 2022, Suzhou Zuoxuanxing Biotechnology Co., Ltd. doing business named Levostar, is a biotechnology company that focuses on providing cell and gene therapy clinical products testing and production. Its team members are from Cornell University, Tsinghua University, Peking University, and other universities and corporations. It completed the seed fund in August 2022, then raised pre-series A funding in January 2023. Besides, it started to build the lab in May 2022 and then performed testing services in October 2022. In June 2023, the firm raised pre-series A funding from new investor Hengxu Capital.

The company self-developed multiple testing and analysis platforms, including strain banking & testing, cell library development and testing, plasmid quality control platform, viral vector QC platform, mRNA QC platform, and CAR cell QC platform. It also operates as a contract Design & Manufacture Organization (CDMO), and provides different levels of plasmids and mRNA.

## Funding rounds

- Seed, Apr 11, 2022 — Bohe Angel Fund, Jifeng Ventures

## Investors

- Bohe Angel Fund — Seed
- Jifeng Ventures (https://capitalatlas.ai/funds/jifeng-ventures) — Seed